Table 2 Comparison of subjects with and without gastroesophageal reflux as measured by 24 hour ambulatory pH probe
From: Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
+pH probe (n = 8) | -pH probe (n = 5) | p value | |
|---|---|---|---|
Age | 33.8 (4.37) | 37 (16.5) | 0.59 |
FEV1 (%) | 51 (17) | 59 (20) | 0.45 |
BMI | 23.5 (2.7) | 21.8 (5/2) | 0.43 |
GSAS | 0.65 (0.29) | 0.59 (0.21) | 0.88 |
+ exacerbations previous two years | 5.5 (1.4) | 4 (0) | 0.33 |